BRK-B vs DLY
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
DLY exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health. The asset is significantly overvalued, trading at $14.18 despite an intrinsic value estimate of $7.21. Furthermore, the dividend profile is a classic 'yield trap,' with a payout ratio of 135.96% suggesting that distributions are not supported by earnings. Combined with a 0/100 technical trend and zero profit margins, the outlook is highly precarious.
Compare Another Pair
Related Comparisons
BRK-B vs DLY: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and DoubleLine Yield Opportunities Fund (DLY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.